David Newby

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

A. Thrift, W. Abhayaratna, J. Attia, 2022, Atherosclerosis.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.

D. Webb, P. Hayes, C. Ludlam, 2008, Thrombosis research.

The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation

D. Newby, N. Mills, F. Denison, 2010, Thrombosis and Haemostasis.

An in vivo Model for the Assessment of Acute Fibrinolytic Capacity of the Endothelium

D. Webb, D. Newby, K. Fox, 1997, Thrombosis and Haemostasis.

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

A. Doney, C. Hawkey, A. Avery, 2022, The Lancet.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.